Lexaria Bioscience's total assets for Q were $8.87M, a decrease of -11.49% from the previous quarter. LEXX total liabilities were $1.21M for the fiscal quarter, a 345.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.